Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCB-2019 Booster in COVID-19
NCT05812586Phase 3Unknown
- Sponsor
- Instituto D’Or de Pesquisa e Ensino
- Start
- Mar 2023
- Primary completion
- Jun 2023
- Modality
- Recombinant Proteins and Enzymes, Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of SCB-2019 in coronavirus disease 2019 (COVID-19), sponsored by Instituto D’Or de Pesquisa e Ensino. Status: unknown.
02
Drugs
SCB-2019
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05812586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05812586.